Abstract
Get full access to this article
View all access options for this article.
References
1.
Culhane
NS
,
Hodle
AD
. Burning mouth syndrome after taking clonazepam . Ann Pharmacother , 35 :874 –876 . 2001 .
2.
Feily
A
,
Namazi
MR
. Aloe vera in dermatology: A brief review . G Ital Dermatol Venereol , 144 :85 –91 . 2009 .
3.
Horn
HM
,
Tidman
MJ
. The clinical spectrum of epidermolysis bullosa simplex . Br J Dermatol , 142 :468 –472 . 2000 .
4.
Jenner
P
,
Pratt
JA
,
Marsden
CD
. Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT . Adv Neurol , 43 :629 –643 . 1986 .
5.
Khoosal
D
,
Goldman
RD
. Vitamin E for treating children's scars . Does it help reduce scarring? Can Fam Physician , 52 :855 –856 . 2006 .
6.
Kirkup
ME
,
Birchall
NM
,
Weinberg
EG
,
Helm
K
,
Kennedy
CT
. Acute and maintenance treatment of atopic dermatitis in children—two comparative studies with fluticasone propionate (0.05%) cream . J Dermatolog Treat , 14 :141 –148 . 2003 .
7.
Klasser
GD
,
Fischer
DJ
,
Epstein
JB
. Burning mouth syndrome: Recognition, understanding, and management . Oral Maxillofac Surg Clin North Am , 20 :255 –271 . 2008 .
8.
Lee
YC
,
Rycroft
RJ
,
White
IR
,
McFadden
JP
. Recurrent focal palmar peeling . Australas J Dermatol , 37 :143 –144 . 1996 .
9.
Litt
JZ
. Drug Eruption Reference Manual . 15th . New York : Informa Healthcare USA, Inc , 2009 .
10.
McCauliffe
DP
. Cutaneous lupus erythematosus . Semin Cutan Med Surg , 20 :14 –26 . 2001 .
11.
Michie
C
,
Kinsler
V
,
Tulloh
R
,
Davidson
S
. Recurrent skin peeling following Kawasaki disease . Arch Dis Child , 83 :353 –355 . 2000 .
12.
Naranjo
CA
,
Busto
U
,
Sellers
EM
,
Sandor
P
,
Ruiz
I
,
Roberts
EA
,
Janecek
E
,
Domecq
C
,
Greenblatt
DJ
. A method for estimating the probability of adverse drug reactions . Clin Pharmacol Ther , 30 :239 –245 . 1981 .
13.
Rahman
S
,
Bhatia
K
,
Khan
AQ
,
Kaur
M
,
Ahmad
F
,
Rashid
H
,
Athar
M
,
Islam
F
,
Raisuddin
S
. Topically applied vitamin E prevents massive cutaneous inflammatory and oxidative stress responses induced by double application of 12-O-tetradecanoylphorbol-13-acetate (TPA) in mice . Chem Biol Interact , 172 :195 –205 . 2008 .
14.
Roeder
A
,
Schaller
M
,
Schäfer-Korting
M
,
Korting
HC
. Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases . Skin Pharmacol Physiol , 18 :3 –11 . 2005 .
15.
Wakade
O
,
Adams
B
,
Shwayder
T
. Acral peeling skin syndrome: A case of two brothers . Pediatr Dermatol , 26 :328 –330 . 2009 .